04 April 2008

Finally, some good news

Seems the FDA finally approved GSK's Rotarix vaccine against rotavirus, which causes vomiting and diarrhea in infants and children.
"Rotarix will compete with Merck’s already marketed Rotateq, a similar product, which is usually given in three doses over the course of six months. Rotateq was Merck’s second-best selling vaccine last year with revenue of $525 million. With only two doses, Rotarix allows infants to complete the vaccination series against rotavirus earlier than ever before, which may prevent many of the emergency department visits and hospitalizations that are a burden on families and the healthcare system,” said Barbara Howe, a company vice president."

Half a billion dollars? And still you wonder why they invent these things...

No comments:

 

Casino Deposit Bonus